HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas.

AbstractOBJECTIVE:
The objective of this study was to elucidate the natural history of late-onset transthyretin Val30Met-associated familial amyloid polyneuropathy (FAP ATTR Val30Met) in non-endemic areas.
METHODS:
The authors retrospectively assessed the development of major clinical landmarks and abnormalities of nerve conduction and cardiac examination indices in 50 patients with an age of onset older than 50 years and no relationship to endemic foci.
RESULTS:
Once the neuropathic process was initiated, sensory and motor symptoms of both the upper and lower extremities appeared within a period of one and a half years. Digestive and orthostatic symptoms also tended to occur in the early phase of the disease, whereas urinary symptoms appeared in the middle of the disease progress. Along with pain in the extremities, these symptoms progressed over time and significantly disturbed the quality of life during the late phase of the disease, resulting in the need for wheelchair use. Although cardiomyopathy became clinically apparent only in the late phase of the disease, it was found to be the major cause of death. The mean duration of the disease onset to death was 7.3 years. Although values at the time of diagnosis were extremely variable, serial measurements of electrophysiological indices, the cardiothoracic ratio and interventricular septum thickness indicated a steady exacerbation in these outcomes among patients within a span of a couple of years.
CONCLUSIONS:
The ages of onset of each clinical landmark were extremely variable between patients. However, once an initial symptom appeared, the chronological sequence of other clinical landmarks tended to be uniform, occurring within a relatively short time span.
AuthorsHaruki Koike, Fumiaki Tanaka, Rina Hashimoto, Minoru Tomita, Yuichi Kawagashira, Masahiro Iijima, Junko Fujitake, Toru Kawanami, Takeo Kato, Masahiko Yamamoto, Gen Sobue
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 83 Issue 2 Pg. 152-8 (Feb 2012) ISSN: 1468-330X [Electronic] England
PMID22228785 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid
  • Prealbumin
Topics
  • Action Potentials (physiology)
  • Age of Onset
  • Aged
  • Amyloid (metabolism)
  • Amyloid Neuropathies, Familial (complications, genetics, physiopathology)
  • Cardiomegaly (diagnostic imaging, etiology)
  • Cause of Death
  • Disease Progression
  • Endemic Diseases
  • Female
  • Follow-Up Studies
  • Heart (physiopathology)
  • Heart Diseases (etiology, therapy)
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Nervous System Diseases (genetics, physiopathology)
  • Neural Conduction (genetics, physiology)
  • Neurologic Examination
  • Pacemaker, Artificial
  • Pain (etiology)
  • Prealbumin (genetics)
  • Retrospective Studies
  • Sensation Disorders (etiology)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: